Approval for stent diameters which expand the product matrix to include 2.25 mm and 4.0mm taxus express2 paclitaxel-eluting coronary stent systems. the device, asmodified, will be marketed under the trade name taxus express2 paclitaxel-elutingcoronary stent system (monorail, mr and over-the-wire, otw) and is indicated for thefollowing: the taxus express paclitaxel-eluting coronary stent system is indicated for improvingluminal diameter for the treatment of de novo lesions in native coronary arteries >2.25 to<4.0mm in diameter in lesions < 28mm in length.